Literature DB >> 20477950

Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain.

Susanna Scafidi1, Gary Fiskum, Steven L Lindauer, Penelope Bamford, Da Shi, Irene Hopkins, Mary C McKenna.   

Abstract

Acetyl-L-carnitine (<span class="Chemical">ALCAR) is an endogenous metabolic intermediate that facilitates the influx and efflux of acetyl groups across the mitochondrial inner membrane. Exogenously administered ALCAR has been used as a nutritional supplement and also as an experimental drug with reported neuroprotective properties and effects on brain metabolism. The aim of this study was to determine oxidative metabolism of ALCAR in the immature rat forebrain. Metabolism was studied in 21-22 day-old rat brain at 15, 60 and 120 min after an intraperitoneal injection of [2-(13)C]acetyl-L-carnitine. The amount, pattern, and fractional enrichment of (13)C-labeled metabolites were determined by ex vivo(13)C-NMR spectroscopy. Metabolism of the acetyl moiety from [2-(13)C]ALCAR via the tricarboxylic acid cycle led to incorporation of label into the C4, C3 and C2 positions of glutamate (GLU), glutamine (GLN) and GABA. Labeling patterns indicated that [2-(13)C]ALCAR was metabolized by both neurons and glia; however, the percent enrichment was higher in GLN and GABA than in GLU, demonstrating high metabolism in astrocytes and GABAergic neurons. Incorporation of label into the C3 position of alanine, both C3 and C2 positions of lactate, and the C1 and C5 positions of glutamate and glutamine demonstrated that [2-(13)C]ALCAR was actively metabolized via the pyruvate recycling pathway. The enrichment of metabolites with (13)C from metabolism of ALCAR was highest in alanine C3 (11%) and lactate C3 (10%), with considerable enrichment in GABA C4 (8%), GLN C3 (approximately 4%) and GLN C5 (5%). Overall, our (13)C-NMR studies reveal that the acetyl moiety of ALCAR is metabolized for energy in both astrocytes and neurons and the label incorporated into the neurotransmitters glutamate and GABA. Cycling ratios showed prolonged cycling of carbon from the acetyl moiety of ALCAR in the tricarboxylic acid cycle. Labeling of compounds formed from metabolism of [2-(13)C]ALCAR via the pyruvate recycling pathway was higher than values reported for other precursors and may reflect high activity of this pathway in the developing brain. This is, to our knowledge, the first study to determine the extent and pathways of ALCAR metabolism for energy and neurotransmitter biosynthesis in the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20477950      PMCID: PMC4949601          DOI: 10.1111/j.1471-4159.2010.06807.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  65 in total

1.  Metabolism is normal in astrocytes in chronically epileptic rats: a (13)C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy.

Authors:  Torun M Melø; Astrid Nehlig; Ursula Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  2005-10       Impact factor: 6.200

2.  Anti-apoptotic effect of acetyl-l-carnitine and I-carnitine in primary cultured neurons.

Authors:  T Ishii; Y Shimpo; Y Matsuoka; K Kinoshita
Journal:  Jpn J Pharmacol       Date:  2000-06

3.  Metabolic compartmentation in cortical synaptosomes: influence of glucose and preferential incorporation of endogenous glutamate into GABA.

Authors:  Ursula Sonnewald; Mary McKenna
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

4.  Carnitine treatment inhibits increases in cerebral carnitine esters and glutamate detected by mass spectrometry after hypoxia-ischemia in newborn rats.

Authors:  Mark S Wainwright; Rohit Kohli; Peter F Whitington; Donald H Chace
Journal:  Stroke       Date:  2005-12-29       Impact factor: 7.914

5.  Approaches to studies on neuronal/glial relationships by 13C-MRS analysis.

Authors:  A Taylor; M McLean; P Morris; H Bachelard
Journal:  Dev Neurosci       Date:  1996       Impact factor: 2.984

6.  Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy.

Authors:  Douglas Ebert; Ronald G Haller; Marlei E Walton
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

7.  The effects of L-carnitine on the combination of, inhalation anesthetic-induced developmental, neuronal apoptosis in the rat frontal cortex.

Authors:  X Zou; N Sadovova; T A Patterson; R L Divine; C E Hotchkiss; S F Ali; J P Hanig; M G Paule; W Slikker; C Wang
Journal:  Neuroscience       Date:  2007-12-15       Impact factor: 3.590

8.  Delayed cerebral oxidative glucose metabolism after traumatic brain injury in young rats.

Authors:  Susanna Scafidi; Janet O'Brien; Irene Hopkins; Courtney Robertson; Gary Fiskum; Mary McKenna
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

9.  Effects of acetyl-L-carnitine on regional cerebral glucose metabolism in awake rats.

Authors:  Carlo Ori; Ulderico Freo; Gilberto Pizzolato; Mauro Dam
Journal:  Brain Res       Date:  2002-10-04       Impact factor: 3.252

Review 10.  Acylcarnitines: role in brain.

Authors:  Lauren L Jones; David A McDonald; Peggy R Borum
Journal:  Prog Lipid Res       Date:  2009-08-29       Impact factor: 16.195

View more
  42 in total

Review 1.  Novel mitochondrial targets for neuroprotection.

Authors:  Miguel A Perez-Pinzon; R Anne Stetler; Gary Fiskum
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-28       Impact factor: 6.200

Review 2.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

3.  Effect of Acetyl-L-carnitine Used for Protection of Neonatal Hypoxic-Ischemic Brain Injury on Acute Kidney Changes in Male and Female Rats.

Authors:  Andrew G Wang; Michele Diamond; Jaylyn Waddell; Mary C McKenna
Journal:  Neurochem Res       Date:  2019-04-30       Impact factor: 3.996

4.  Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery.

Authors:  S P Patel; P G Sullivan; T S Lyttle; D S K Magnuson; A G Rabchevsky
Journal:  Neuroscience       Date:  2012-03-15       Impact factor: 3.590

Review 5.  L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

Authors:  Gustavo C Ferreira; Mary C McKenna
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

6.  Beneficial Effects of Kaempferol after Developmental Traumatic Brain Injury Is through Protection of Mitochondrial Function, Oxidative Metabolism, and Neural Viability.

Authors:  Jyothsna Chitturi; Vijayalakshmi Santhakumar; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2019-01-08       Impact factor: 5.269

7.  Acetyl-l-carnitine deficiency in patients with major depressive disorder.

Authors:  Carla Nasca; Benedetta Bigio; Francis S Lee; Sarah P Young; Marin M Kautz; Ashly Albright; James Beasley; David S Millington; Aleksander A Mathé; James H Kocsis; James W Murrough; Bruce S McEwen; Natalie Rasgon
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

8.  Augmentation of normal and glutamate-impaired neuronal respiratory capacity by exogenous alternative biofuels.

Authors:  Melissa D Laird; Pascaline Clerc; Brian M Polster; Gary Fiskum
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

Review 9.  Acetyl-L-carnitine in hepatic encephalopathy.

Authors:  Michele Malaguarnera
Journal:  Metab Brain Dis       Date:  2013-02-08       Impact factor: 3.584

10.  Sex-dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic-ischemic encephalopathy.

Authors:  Tyler G Demarest; Rosemary A Schuh; Jaylyn Waddell; Mary C McKenna; Gary Fiskum
Journal:  J Neurochem       Date:  2016-05-06       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.